Raleigh Capital Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
Other funds holding LH
RRAM
JIC
BCWM
AAM
DIA
SFA
WCM
HPCM
MCM
ET
Raleigh Capital Management's LH Position: Q2 2026 in Review
Raleigh Capital Management reduced its Labcorp (LH) stake by 0.71% in Q2 2026, selling an estimated $263 and leaving 139 shares worth $39K. The position accounts for 0.01% of the portfolio, ranked #293.
Raleigh Capital Management first reported a position in LH in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.27M in Q3 2025. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Raleigh Capital Management held 139 shares of Labcorp worth $39K as of Q2 2026.
- Raleigh Capital Management sold 1 Labcorp share in Q2 2026, an estimated $263.
- Labcorp made up 0.01% of Raleigh Capital Management's portfolio in Q2 2026, its #293 holding.
- Raleigh Capital Management first reported a position in Labcorp in Q4 2021 and has held it in 19 quarters since.
- Raleigh Capital Management's Labcorp position peaked at $3.27M in Q3 2025.
- 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Raleigh Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.